Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational dia…
Biotechnology
US, Austin [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Cassava Sciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCassava Sciences, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Cassava Sciences, Inc..
If you want to see a demo, head over to the financial segments of AAPL